Horizon Investments LLC Purchases 2,916 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Horizon Investments LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 11,884 shares of the medical equipment provider’s stock after buying an additional 2,916 shares during the quarter. Horizon Investments LLC’s holdings in Intuitive Surgical were worth $6,203,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $558,807,000. Proficio Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares in the last quarter. FMR LLC boosted its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Intuitive Surgical in the 4th quarter worth about $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its position in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $488.80 on Tuesday. The company has a market cap of $174.10 billion, a P/E ratio of 76.26, a PEG ratio of 5.85 and a beta of 1.43. The firm has a 50-day simple moving average of $566.38 and a two-hundred day simple moving average of $531.96. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Insider Buying and Selling

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on ISRG shares. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Royal Bank of Canada boosted their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $610.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.